Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination (Q39443721)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination |
scientific article |
Statements
1 reference
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination (English)
1 reference
Michael Millward
1 reference
Timothy Price
1 reference
Amanda Townsend
1 reference
Christopher Sweeney
1 reference
Andrew Spencer
1 reference
Shawgi Sukumaran
1 reference
Angie Longenecker
1 reference
Lonnie Lee
1 reference
Ana Lay
1 reference
Girish Sharma
1 reference
Robert M Gemmill
1 reference
Harry A Drabkin
1 reference
G Kenneth Lloyd
1 reference
Saskia T C Neuteboom
1 reference
David J McConkey
1 reference
Michael A Palladino
1 reference
Matthew A Spear
1 reference
12 November 2011
1 reference
1 reference
2303-2317
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference